Purpose: Rituximab-based chemotherapy improves outcomes in B-cell non-Hodgkin lymphoma (NHL), but may exacerbate treatment-related immunosuppression, increasing the risk of opportunistic infections. Infection prophylaxis is not r... ...

请注册登录后继续浏览